MedPath

Dr. Tapas K. Das Gupta

Ownership
Private
Employees
-
Market Cap
-
Website

Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment

Phase 1
Completed
Conditions
Refractory Solid Tumors
Interventions
First Posted Date
2009-06-05
Last Posted Date
2014-10-28
Lead Sponsor
Dr. Tapas K. Das Gupta
Target Recruit Count
15
Registration Number
NCT00914914
Locations
🇺🇸

University of Illinois at Chicago Department of Surgical Oncology, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath